“The action is where the medical cannabis export markets are, which are much larger than Canada,” said Chris Damas, editor of the BCMI Cannabis Report. “CanniMed has patents, they have relationships with different universities, research and clinical trials, and export relations with other countries, and Aurora wants to add to their own relationships in Europe.”
The trial reduced the frequency of seizures in patients with the illness, just 10% of whom had previously been found to respond to conventional drug treatments, though the authors say that efficacy and safety of the new treatment ‘now needs to be confirmed’.
The Federal Government will invest the money in world-leading medical researchers to target devastating and rare conditions like acute lymphoblastic leukaemia in infants, aplastic anaemia, multiple sclerosis and Huntington’s disease.
Mr Jones joins Jeremy Kyle and Durham’s Police, Crime and Victims Commissioner Ron Hogg as the latest in a line of public figures who have asked club members to share their experiences as they consider the debate around marijuana use, which is now legal in a number of countries.
Amid the harsh sentences meted out to those who abuse cannabis, scientists at the National Research Foundation (NRF) are working to access the medicinal potential of the chemical compounds found in cannabis – cannabinoids – without negative side effects.
Legal marijuana is a multi-billion industry, with nearly every transaction done in cash.
“The only thing that’s really helped me with all these symptoms is cannabis [marijuana],” Pereyda said. “The pain, anger, mood swings, appetite, my sleep, all have been addressed by this one plant. I got my life back.”
“At the very least, people who are using marijuana to treat chronic illness and make their lives possible shouldn’t live under the constant threat of being arrested,” he said recently.
We urgently need high-quality observational research studies to be able to better understand the effects of marijuana on work. We also need to develop an accurate measure of impairment for use in Canadian workplaces.